FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061036594> ?p ?o ?g. }

• W2061036594 endingPage "117" @default.
• W2061036594 startingPage "100" @default.
• W2061036594 abstract "To establish the bioequivalence (BE) between two i.m. estradiol valerate (E2V) depot formulations, i.e., Estradiol-Depot 10 mg® (test) and Progynon Depot-10® (reference). To compare the effect of both treatments on the vaginal maturation index and on the increase of the endometrial thickness after administration of both formulations.A total of 24 postmenopausal females aged 54.7 ± 5.35 year (BMI 25.84 ± 1.98 kg/m2) completed this BE assessment. The investigation was planned and designed as a single center, openlabel, single dose, cross-over study including 2 periods with 2 treatments and 2 sequences. Baseline levels were obtained for all subjects. Single doses of 10-mg E2V of each product were administered and pharmacokinetics and pharmacodynamics were assessed over 2 weeks with a washout period of 4 weeks. A gas chromatographic-mass spectrometric method with negative chemical ionization and selected ion monitoring was applied, after validation, for the determination of estradiol (E2), estrone (E1) and internal standard estradiol-D4 derivatives. The cytology of the vaginal smear (parabasal, intermediate and superficial cells from lateral wall opposite tip of cervix) was assessed by investigation of ~ 200 cells. The vaginal maturation index (VMI) was calculated by the equation: VMI (%) = (superficial cells × 1) (%) + (intermediate cells × 0.5) (%). Endometrial thickness was measured by transvaginal ultrasonic scans and recorded in mm.The geometric means (Gmeans) of the measured values of Cmax and AUC0-t for E2 were 543.5 pg/ ml and 84,734 pg × h/ml for test and 505.7 pg/ml and 82,660 pg × h/ml for reference, whereas those for E1 were 219.0 pg/ml and 38,950 pg × h/ml for test and 204.9 pg/ml and 37,159 pg × h/ml for reference, respectively. The point estimates (PEs) of the Test/ Reference (T/R) mean ratios of the variables Cmax and AUC0-t for E2 (measured values) were 107.3% and 102.5%, respectively. The PEs of the T/R mean ratios of the variables Cmax and AUC0-t for E1 (measured values) were 106.9% and 105.0%, respectively. Median endometrial thickness increased in Period I from baseline levels of ~ 3 mm (Day -2) to ~ 7 mm (Day 21) after administration of both products without returning completely to baseline prior to the next administration. In Period II, median values of 7 mm were also reached (Day 21) after administration of both products. Median vaginal maturation indices increased in Period I from baseline levels of ranging from 45 - 60% (Day -2) to 86 - 94.5% (Day 21). In Period II maturation indices of ≥ 90% were calculated as baselines (Day -2) and these levels remained constant until the end of the assessment (Day 21) independently from the products. After 21 days of treatment, test and reference presented practically no differences in terms of their effects on endometrial thickness and vaginal maturation index.The 95% CIs for the T/R mean ratios of AUC0-t and Cmax for E2 and E1 fell within the acceptance limits of 80 - 125% and therefore bioequivalence could be demonstrated for both formulations. The changes in endometrial thickness and the vaginal maturation index indicated that the pharmacodynamic effect is pronounced already after the first administration and that the effect continued notably for longer time compared to the presence of E2 and E1 in plasma. A 4-week washout phase was insufficient to avoid residual pharmacological effects after the administration of both preparations." @default.
• W2061036594 created "2016-06-24" @default.
• W2061036594 creator A5026056908 @default.
• W2061036594 creator A5045409792 @default.
• W2061036594 creator A5056136043 @default.
• W2061036594 date "2012-02-01" @default.
• W2061036594 modified "2023-09-27" @default.
• W2061036594 title "Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers" @default.
• W2061036594 doi "https://doi.org/10.5414/cp201589" @default.
• W2061036594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22257576" @default.
• W2061036594 hasPublicationYear "2012" @default.
• W2061036594 type Work @default.
• W2061036594 sameAs 2061036594 @default.
• W2061036594 citedByCount "2" @default.
• W2061036594 countsByYear W20610365942014 @default.
• W2061036594 countsByYear W20610365942020 @default.
• W2061036594 crossrefType "journal-article" @default.
• W2061036594 hasAuthorship W2061036594A5026056908 @default.
• W2061036594 hasAuthorship W2061036594A5045409792 @default.
• W2061036594 hasAuthorship W2061036594A5056136043 @default.
• W2061036594 hasConcept C100544194 @default.
• W2061036594 hasConcept C111113717 @default.
• W2061036594 hasConcept C112705442 @default.
• W2061036594 hasConcept C134018914 @default.
• W2061036594 hasConcept C166957645 @default.
• W2061036594 hasConcept C181389837 @default.
• W2061036594 hasConcept C185592680 @default.
• W2061036594 hasConcept C22979827 @default.
• W2061036594 hasConcept C2776561332 @default.
• W2061036594 hasConcept C2776753739 @default.
• W2061036594 hasConcept C2776979534 @default.
• W2061036594 hasConcept C2777164284 @default.
• W2061036594 hasConcept C2778001906 @default.
• W2061036594 hasConcept C2778656385 @default.
• W2061036594 hasConcept C31903555 @default.
• W2061036594 hasConcept C42404028 @default.
• W2061036594 hasConcept C71924100 @default.
• W2061036594 hasConcept C95457728 @default.
• W2061036594 hasConcept C98274493 @default.
• W2061036594 hasConceptScore W2061036594C100544194 @default.
• W2061036594 hasConceptScore W2061036594C111113717 @default.
• W2061036594 hasConceptScore W2061036594C112705442 @default.
• W2061036594 hasConceptScore W2061036594C134018914 @default.
• W2061036594 hasConceptScore W2061036594C166957645 @default.
• W2061036594 hasConceptScore W2061036594C181389837 @default.
• W2061036594 hasConceptScore W2061036594C185592680 @default.
• W2061036594 hasConceptScore W2061036594C22979827 @default.
• W2061036594 hasConceptScore W2061036594C2776561332 @default.
• W2061036594 hasConceptScore W2061036594C2776753739 @default.
• W2061036594 hasConceptScore W2061036594C2776979534 @default.
• W2061036594 hasConceptScore W2061036594C2777164284 @default.
• W2061036594 hasConceptScore W2061036594C2778001906 @default.
• W2061036594 hasConceptScore W2061036594C2778656385 @default.
• W2061036594 hasConceptScore W2061036594C31903555 @default.
• W2061036594 hasConceptScore W2061036594C42404028 @default.
• W2061036594 hasConceptScore W2061036594C71924100 @default.
• W2061036594 hasConceptScore W2061036594C95457728 @default.
• W2061036594 hasConceptScore W2061036594C98274493 @default.
• W2061036594 hasIssue "02" @default.
• W2061036594 hasLocation W20610365941 @default.
• W2061036594 hasLocation W20610365942 @default.
• W2061036594 hasOpenAccess W2061036594 @default.
• W2061036594 hasPrimaryLocation W20610365941 @default.
• W2061036594 hasRelatedWork W1984498366 @default.
• W2061036594 hasRelatedWork W2011337719 @default.
• W2061036594 hasRelatedWork W2033685750 @default.
• W2061036594 hasRelatedWork W2061036594 @default.
• W2061036594 hasRelatedWork W2354680669 @default.
• W2061036594 hasRelatedWork W2359939078 @default.
• W2061036594 hasRelatedWork W2374069256 @default.
• W2061036594 hasRelatedWork W2401080248 @default.
• W2061036594 hasRelatedWork W2611950068 @default.
• W2061036594 hasRelatedWork W4030067 @default.
• W2061036594 hasVolume "50" @default.
• W2061036594 isParatext "false" @default.
• W2061036594 isRetracted "false" @default.
• W2061036594 magId "2061036594" @default.
• W2061036594 workType "article" @default.